US4758434A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant
Assignee: HERCON LABORATORIES Corp A CORP OF DELAWARE
•
Filing: 1986-04-03
•
Granted: 1988-07-19
•
Expires: 2006-04-03
Abstract
Abstract Described is an article of manufacture useful for administration of pharmacologically-active substances, transdermally, orally or by means of subdermal implant comprising a solid vinyl plastisol layer for contacting a patient's tissue, internally or externally, the layer containing from about 20 up to about 70% by weight of a polyvinyl chloride resin or a polyvinyl chloride-polyvinyl acetate copolymer containing a minor proportion of vinyl acetate; from about 20-70% plasticizer composition; from abotu 0.5 up to 35% of pharmacologically-active substance such as isosorbide dinitrate, nicotine, clonidine, guanfacine, indomethacin, glyceryl trinitrate and prostaglandin and optionally excipients. Also described is the novel plasticizer-polyvinyl chloride composition of matter comprising 1-dodecylhexahydro-2H-azepin-2-one and polyvinyl chloride resin taken together with a pharmacologically-active substance whereint he 1-dodecylhexahydro-2H-azepin-2-one not only acts as a plasticizer but also acts as a penetration enhancer (through tissue) for the pharmacologically-active substance.
Inventors
- 👤 Agis Kydonieus
- 👤 Kishore R. Shah
- 👤 Bret Berner
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 01:57
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K31/00; A61K31/21; A61K9/7084; A61M; A61M31/00; A61M31/002
Claims Analysis
Total Claims: 33
Claim 1
Independent Claim
143 words
A device for the controlled release and delivery to human tissue of a pharmacologically-active agent comprising a solid vinyl plastisol layer comprising by weight from about 30 up to about 50% polyvinyl chloride resin; from about 20 up to about 70% of plasticizer and from about 0.5 up to about 35% of said pharmacologically-active substance which when a surface of said layer is in contact with a tissue either exterior to the human epidermis or subdermally or in contact with a tissue of an animal to be treated with said pharmacologically-active agent, said pharmacologically-active agent is absorbed into and through said tissue and thence into circulatory system of said animal, said pharmacologically-active agent being uniformly dispersed in said plastisol layer in an amount such that an effective amount of said pharmacologically-active agent is absorbed into said animal in a prescribed period of time.
Claim 2
Independent Claim
143 words
A device for the controlled release and delivery to human tissue of a pharmacologically-active agent comprising a solid vinyl plastisol layer comprising by weight from about 30 up to about 50% polyvinyl chloride resin; from about 20 up to about 70% of plasticizer and from about 0.5 up to about 35% of said pharmacologically-active substance which when a surface of said layer is in contact with a tissue either exterior to the human epidermis or subdermally or in contact with a tissue of an animal to be treated with said pharmacologically-active agent, said pharmacologically-active agent is absorbed into and through said tissue and thence into circulatory system of said animal, said pharmacologically-active agent being uniformly dispersed in said plastisol layer in an amount such that an effective amount of said pharmacologically-active agent is absorbed into said animal in a prescribed period of time.
Claim 3
Dependent Claim
23 words
The device of claim 1 wherein control membranes for secondary control of release are attached on one or both sides of said device.
Claim 4
Dependent Claim
12 words
The device of claim 1 wherein the plasticizer is a polymeric plasticizer.
Claim 5
Dependent Claim
12 words
The device of claim 1 wherein the plasticizer is a monomeric plasticizer.
Claim 6
Dependent Claim
11 words
The article of claim 1 wherein the plasticizer is dioctyl phthalate.
Claim 7
Dependent Claim
19 words
The article of claim 3 wherein the polymeric plasticizer is a polyphthalate having the IR spectrum of FIG. 12.
Claim 8
Dependent Claim
13 words
The article of claim 3 wherein the polymeric plasticizer is epoxidized soybean oil.
Claim 9
Dependent Claim
39 words
The article of claim 2 wherein the polyvinyl chloride is present in an amount of about 30-50%, the plasticizer is present in an amount of about 30-60% and the pharmacologically-active agent is present in an amount of about 0.5-35%.
Claim 10
Dependent Claim
12 words
The article of claim 1 in the form of an elongated tape.
Claim 11
Dependent Claim
40 words
The article of claim 9 wherein said plastisol layer comprises polyvinyl chloride resin, a polymeric plasticizer or a monomeric plasticizer and a pharmacologically-active agent selected from the group consisting of isosorbide dinitrate, nicotine, indomethacin, clonidine, glyercyl trinitrate, guanfacine and prostaglandin.
Claim 12
Dependent Claim
44 words
The article of claim 10 wherein said polyvinyl chloride is present in an amount of about 30-50%, said plasticizer is present in an amount of about 30-60% and said pharmacologically-active agent is present in an amount of from about 0.5 up to about 35%.
Claim 13
Dependent Claim
23 words
The article of claim 11 wherein the pharmacologically-active active agent is nitroglycerin and the nitroglycerin is present in an amount of about 20-35%.
Claim 14
Dependent Claim
33 words
The article of claim 11 wherein said tape is provided with indicia indicating the length of a segment of said tape which is adequate to administer a prescribed dosage of said pharmacologically-active substance.
Claim 15
Dependent Claim
31 words
The article of claim 9 in the form of a roll of tape of sufficient length to provide multiple tape segments adequate to provide a prescribed dosage of said pharmacologically-active agent.
Claim 16
Independent Claim
204 words
A device for the controlled release and transdermal delivery of a pharmacologically-active agent comprising, a solid vinyl plastisol layer comprising by weight from about 30 up to about 50% of a polyvinyl chloride resin; from about 20 up to about 70% of a plasticizer and from about 0.5 up to about 35% of a pharmacologically-active agent which, when a surface of said layer is in contact with the skin of an animal to be treated with said pharmacologically-active agent, is absorbed into and through skin and thence into the circulatory system of said animal, said pharmacologically-active agent being uniformly dispersed in said plastisol layer in an amount such that an effective amount of the pharmacologically-active agent is absorbed through the skin of said animal in a prescribed period of time, a backing layer covering the surface of said plastisol layer opposite the skin contacting surface of said plastisol layer, said backing layer forming a barrier substantially blocking release of said pharmacologically-active agent from the surface of said plastisol layer opposite the skin contacting surface, and means for maintaining the skin contacting surface of said plastisol layer in contact with the skin of said animal so that transdermal absorption of said pharmacologically-active agent takes place.
Claim 17
Independent Claim
204 words
A device for the controlled release and transdermal delivery of a pharmacologically-active agent comprising, a solid vinyl plastisol layer comprising by weight from about 30 up to about 50% of a polyvinyl chloride resin; from about 20 up to about 70% of a plasticizer and from about 0.5 up to about 35% of a pharmacologically-active agent which, when a surface of said layer is in contact with the skin of an animal to be treated with said pharmacologically-active agent, is absorbed into and through skin and thence into the circulatory system of said animal, said pharmacologically-active agent being uniformly dispersed in said plastisol layer in an amount such that an effective amount of the pharmacologically-active agent is absorbed through the skin of said animal in a prescribed period of time, a backing layer covering the surface of said plastisol layer opposite the skin contacting surface of said plastisol layer, said backing layer forming a barrier substantially blocking release of said pharmacologically-active agent from the surface of said plastisol layer opposite the skin contacting surface, and means for maintaining the skin contacting surface of said plastisol layer in contact with the skin of said animal so that transdermal absorption of said pharmacologically-active agent takes place.
Claim 18
Dependent Claim
28 words
The device of claim 15 wherein a rate controlling membrane is attached to the plastisol layer on the side of the plastisol layer opposite to the backing layer.
Claim 19
Dependent Claim
46 words
An article of claim 15 or 16 wherein the means for maintaining the skin contacting surface of said plastisol layer in contact with the skin is a pressure sensitive adhesive adhered to the plastisol layer on the side of the plastisol layer opposite said backing layer.
Claim 20
Dependent Claim
52 words
An article of claim 15 or 16 wherein the means for maintaining the skin contacting surface of said plastisol layer in contact with the skin is a pressure sensitive adhesive layer adhered to the side of the backing layer opposite the plastisol layer and extending beyond the periphery of the plastisol layer.
Claim 21
Dependent Claim
18 words
The device of claim 15 or 16 wherein said plasticizer is a polymeric plasticizer or a monomeric plasticizer.
Claim 22
Dependent Claim
19 words
The article of claim 19 wherein the polymeric plasticizer is a polyphthalate having the IR spectrum of FIG. 12.
Claim 23
Dependent Claim
11 words
The article of claim 19 wherein the plasticizer is dioctyl phthalate.
Claim 24
Dependent Claim
13 words
The article of claim 19 wherein the polymeric plasticizer is epoxidized soybean oil.
Claim 25
Dependent Claim
41 words
The device of claim 15 or 16 wherein said polyvinyl chloride is present in an amount of about 30-50%, said plasticizer is present in an amount of about 30-60%, and said pharmacologically-active agent is present in an amount of about 0.5-35%.
Claim 26
Dependent Claim
12 words
The device of claim 17 in the form of an elongated tape.
Claim 27
Dependent Claim
12 words
The device of claim 24 wherein the plasticizer is a polymeric plasticizer.
Claim 28
Dependent Claim
39 words
The device of claim 25 wherein said polyvinyl chloride is present in an amount of about 30-50%, said plasticizer is present in an amount of about 30-60%, and said pharmacologically-active agent is present in an amount of about 0.5-35%.
Claim 29
Dependent Claim
33 words
The device of claim 24 wherein said tape is provided with indicia indicating the length of a segment of said tape which is adequate to administer a prescribed dosage of said pharmacologically-active agent.
Claim 30
Dependent Claim
30 words
The device of claim 24 in the form of a roll of tape of sufficient length to provide multiple tape segments adequate to provide a prescribed dosage of said drug.
Claim 31
Dependent Claim
17 words
The article of manufacture of claim 1 wherein the plasticizer is the compound having the structure: ##STR27##
Claim 32
Dependent Claim
12 words
The article of manufacture or claim 1 wherein the plasticizer is N,N-diethyltoluamide.
Claim 33
Dependent Claim
26 words
The article of claim 2 or 16 wherein the rate controlling membrane comprises an ethylene-methyl acrylate copolymer having 2-90% by weight of methyl acrylate monomeric units.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-07-19 | 1992-01-18 | 1992-07-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-07-19 | 1996-01-18 | 1996-07-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-07-19 | 2000-01-18 | 2000-07-19 | $7700.00 | Window Closed / Lapsed |